{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T07:48:30Z","timestamp":1794815310322,"version":"4.9.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"8098","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,1,22]]},"DOI":"10.1038\/s41586-025-09869-0","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T16:01:46Z","timestamp":1765382506000},"page":"1013-1021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Fasting boosts breast cancer therapy efficacy via glucocorticoid activation"],"prefix":"10.1038","volume":"649","author":[{"given":"Nuno","family":"Padr\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesa M.","family":"Severson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9209-5403","authenticated-orcid":false,"given":"Sebastian","family":"Gregoricchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1595-2173","authenticated-orcid":false,"given":"Ana","family":"Guijarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Taranto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ligorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Persia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merel","family":"Roest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Ying","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6586-9079","authenticated-orcid":false,"given":"Sara","family":"Pires-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Donaldson Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4782-8828","authenticated-orcid":false,"given":"Hugo","family":"Horlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7080-9807","authenticated-orcid":false,"given":"Livia","family":"Pisciotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"de Braud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Vernieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5479-641X","authenticated-orcid":false,"given":"Leila","family":"Akkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9264-9792","authenticated-orcid":false,"given":"Jos","family":"Jonkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5068-8884","authenticated-orcid":false,"given":"Alessio","family":"Nencioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1111-9915","authenticated-orcid":false,"given":"Irene","family":"Caffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9823-7289","authenticated-orcid":false,"given":"Wilbert","family":"Zwart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"9869_CR1","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1056\/NEJMra1307118","volume":"383","author":"HJ Burstein","year":"2020","unstructured":"Burstein, H. J. Systemic therapy for estrogen receptor-positive, HER2-negative breast cancer. N. Engl. J. Med. 383, 2557\u20132570 (2020).","journal-title":"N. Engl. J. Med."},{"key":"9869_CR2","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan, H. et al. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 Years. N. Engl. J. Med. 377, 1836\u20131846 (2017).","journal-title":"N. Engl. J. Med."},{"key":"9869_CR3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41586-020-2502-7","volume":"583","author":"I Caffa","year":"2020","unstructured":"Caffa, I. et al. Fasting-mimicking diet and hormone therapy induce breast cancer regression. Nature 583, 620\u2013624 (2020).","journal-title":"Nature"},{"key":"9869_CR4","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.cmet.2024.06.013","volume":"36","author":"DA Koppold","year":"2024","unstructured":"Koppold, D. A. et al. International consensus on fasting terminology. Cell Metab. 36, 1779\u20131794.e1774 (2024).","journal-title":"Cell Metab."},{"key":"9869_CR5","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.3390\/cancers13164013","volume":"13","author":"F Valdemarin","year":"2021","unstructured":"Valdemarin, F. et al. Safety and feasibility of fasting-mimicking diet and effects on nutritional status and circulating metabolic and inflammatory factors in cancer patients undergoing active treatment. Cancers 13, 4013 (2021).","journal-title":"Cancers"},{"key":"9869_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/2159-8290.CD-21-0030","volume":"12","author":"C Vernieri","year":"2022","unstructured":"Vernieri, C. et al. Fasting-mimicking diet is safe and reshapes metabolism and antitumor immunity in patients with cancer. Cancer Discov. 12, 90\u2013107 (2022).","journal-title":"Cancer Discov."},{"key":"9869_CR7","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.cmet.2024.06.014","volume":"36","author":"C Vernieri","year":"2024","unstructured":"Vernieri, C., Ligorio, F., Tripathy, D. & Longo, V. D. Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence. Cell Metab, 36, 1644\u20131667 (2024).","journal-title":"Cell Metab,"},{"key":"9869_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1200\/JCO.18.01160","volume":"37","author":"HJ Burstein","year":"2018","unstructured":"Burstein, H. J. et al. Adjuvant endocrine therapy for women with hormone receptor\u2013positive breast cancer: ASCO clinical practice guideline focused update. J. Clin. Oncol. 37, 423\u2013438 (2018).","journal-title":"J. Clin. Oncol."},{"key":"9869_CR9","doi-asserted-by":"publisher","first-page":"21931","DOI":"10.1073\/pnas.1016071107","volume":"107","author":"MP Creyghton","year":"2010","unstructured":"Creyghton, M. P. et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl Acad. Sci. USA 107, 21931\u201321936 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9869_CR10","doi-asserted-by":"publisher","first-page":"D729","DOI":"10.1093\/nar\/gky1094","volume":"47","author":"R Zheng","year":"2019","unstructured":"Zheng, R. et al. Cistrome Data Browser: expanded datasets and new tools for gene regulatory analysis. Nucleic Acids Res. 47, D729\u2013d735 (2019).","journal-title":"Nucleic Acids Res."},{"key":"9869_CR11","first-page":"129","volume":"1072","author":"P Angel","year":"1991","unstructured":"Angel, P. & Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129\u2013157 (1991).","journal-title":"Biochim. Biophys. Acta"},{"key":"9869_CR12","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/sj.onc.1204383","volume":"20","author":"E Shaulian","year":"2001","unstructured":"Shaulian, E. & Karin, M. AP-1 in cell proliferation and survival. Oncogene 20, 2390\u20132400 (2001).","journal-title":"Oncogene"},{"key":"9869_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/sj.onc.1210643","volume":"27","author":"Q Shen","year":"2008","unstructured":"Shen, Q. et al. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors. Oncogene 27, 366\u2013377 (2008).","journal-title":"Oncogene"},{"key":"9869_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/372107a0","volume":"372","author":"A Fanjul","year":"1994","unstructured":"Fanjul, A. et al. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372, 107\u2013111 (1994).","journal-title":"Nature"},{"key":"9869_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1164-6","volume":"21","author":"E Tonsing-Carter","year":"2019","unstructured":"Tonsing-Carter, E. et al. Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association. Breast Cancer Res. 21, 82 (2019).","journal-title":"Breast Cancer Res."},{"key":"9869_CR16","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202317737","volume":"15","author":"S Prekovic","year":"2023","unstructured":"Prekovic, S. et al. Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity. EMBO Mol. Med. 15, e17737 (2023).","journal-title":"EMBO Mol. Med."},{"key":"9869_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature14583","volume":"523","author":"H Mohammed","year":"2015","unstructured":"Mohammed, H. et al. Progesterone receptor modulates ER\u03b1 action in breast cancer. Nature 523, 313\u2013317 (2015).","journal-title":"Nature"},{"key":"9869_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41591-020-01168-7","volume":"27","author":"TE Hickey","year":"2021","unstructured":"Hickey, T. E. et al. The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer. Nat. Med. 27, 310\u2013320 (2021).","journal-title":"Nat. Med."},{"key":"9869_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-11-98","volume":"11","author":"S Kocanova","year":"2010","unstructured":"Kocanova, S., Mazaheri, M., Caze-Subra, S. & Bystricky, K. Ligands specify estrogen receptor alpha nuclear localization and degradation. BMC Cell Biol. 11, 98 (2010).","journal-title":"BMC Cell Biol."},{"key":"9869_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06676-0","volume":"7","author":"M Stortz","year":"2017","unstructured":"Stortz, M. et al. Mapping the dynamics of the glucocorticoid receptor within the nuclear landscape. Sci. Rep. 7, 6219 (2017).","journal-title":"Sci. Rep."},{"key":"9869_CR21","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/j.cmet.2021.10.008","volume":"33","author":"G Salvadori","year":"2021","unstructured":"Salvadori, G. et al. Fasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escape. Cell Metab. 33, 2247\u20132259.e2246 (2021).","journal-title":"Cell Metab."},{"key":"9869_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.cmet.2024.11.004","volume":"37","author":"F Ligorio","year":"2025","unstructured":"Ligorio, F. et al. Early downmodulation of tumor glycolysis predicts response to fasting-mimicking diet in triple-negative breast cancer patients. Cell Metab. 37, 330\u2013344.e337 (2025).","journal-title":"Cell Metab."},{"key":"9869_CR23","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.3390\/ijms21218127","volume":"21","author":"A Schulze","year":"2020","unstructured":"Schulze, A., Oshi, M., Endo, I. & Takabe, K. MYC targets scores are associated with cancer aggressiveness and poor survival in ER-positive primary and metastatic breast cancer. Int. J. Mol. Sci. 21, 8127 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"9869_CR24","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3390\/cells9071643","volume":"9","author":"M Oshi","year":"2020","unstructured":"Oshi, M. et al. The E2F pathway score as a predictive biomarker of response to neoadjuvant therapy in ER+\/HER2\u2212 breast cancer. Cells 9, 1643 (2020).","journal-title":"Cells"},{"key":"9869_CR25","doi-asserted-by":"publisher","first-page":"707372","DOI":"10.3389\/fragi.2021.707372","volume":"2","author":"SA Fernandes","year":"2021","unstructured":"Fernandes, S. A. & Demetriades, C. The multifaceted role of nutrient sensing and mTORC1 signaling in physiology and aging. Front. Aging 2, 707372 (2021).","journal-title":"Front. Aging"},{"key":"9869_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","volume":"33","author":"AL Buchman","year":"2001","unstructured":"Buchman, A. L. Side effects of corticosteroid therapy. J. Clin. Gastroenterol. 33, 289\u2013294 (2001).","journal-title":"J. Clin. Gastroenterol."},{"key":"9869_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF00132932","volume":"2","author":"PL Lollini","year":"1984","unstructured":"Lollini, P. L. et al. High-metastatic clones selected in vitro from a recent spontaneous BALB\/c mammary adenocarcinoma cell line. Clin. Exp. Metastasis 2, 251\u2013259 (1984).","journal-title":"Clin. Exp. Metastasis"},{"key":"9869_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s43018-023-00525-y","volume":"4","author":"FK Turrell","year":"2023","unstructured":"Turrell, F. K. et al. Age-associated microenvironmental changes highlight the role of PDGF-C in ER+ breast cancer metastatic relapse. Nat. Cancer 4, 468\u2013484 (2023).","journal-title":"Nat. Cancer"},{"key":"9869_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100939","volume":"78","author":"I Mayayo-Peralta","year":"2021","unstructured":"Mayayo-Peralta, I., Prekovic, S. & Zwart, W. Estrogen receptor on the move: cistromic plasticity and its implications in breast cancer. Mol. Aspects Med. 78, 100939 (2021).","journal-title":"Mol. Aspects Med."},{"key":"9869_CR30","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1158\/1078-0432.CCR-22-2060","volume":"29","author":"A El\u00eda","year":"2023","unstructured":"El\u00eda, A. et al. Beneficial effects of mifepristone treatment in patients with breast cancer selected by the progesterone receptor isoform ratio: results from the MIPRA trial. Clin. Cancer Res. 29, 866\u2013877 (2023).","journal-title":"Clin. Cancer Res."},{"key":"9869_CR31","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1210\/en.2004-0411","volume":"146","author":"OC Meijer","year":"2005","unstructured":"Meijer, O. C. et al. Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling. Endocrinology 146, 1438\u20131448 (2005).","journal-title":"Endocrinology"},{"key":"9869_CR32","first-page":"R710","volume":"271","author":"PJ Havel","year":"1996","unstructured":"Havel, P. J. et al. Predominately glucocorticoid agonist actions of RU-486 in young specific-pathogen-free Zucker rats. Am. J. Physiol. 271, R710\u2013R717 (1996).","journal-title":"Am. J. Physiol."},{"key":"9869_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1096\/fj.13-237958","volume":"28","author":"L Besedovsky","year":"2014","unstructured":"Besedovsky, L., Born, J. & Lange, T. Endogenous glucocorticoid receptor signaling drives rhythmic changes in human T-cell subset numbers and the expression of the chemokine receptor CXCR4. FASEB J. 28, 67\u201375 (2014).","journal-title":"FASEB J."},{"key":"9869_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.immuni.2007.05.016","volume":"27","author":"MJ Butte","year":"2007","unstructured":"Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H. & Freeman, G. J. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27, 111\u2013122 (2007).","journal-title":"Immunity"},{"key":"9869_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-84","volume":"8","author":"BD Keith","year":"2008","unstructured":"Keith, B. D. Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy. BMC Cancer 8, 84 (2008).","journal-title":"BMC Cancer"},{"key":"9869_CR36","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/bjc.1988.273","volume":"58","author":"RD Rubens","year":"1988","unstructured":"Rubens, R. D. et al. Prednisolone improves the response to primary endocrine treatment for advanced breast cancer. Br. J. Cancer 58, 626\u2013630 (1988).","journal-title":"Br. J. Cancer"},{"key":"9869_CR37","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/0277-5379(82)90134-1","volume":"18","author":"JF Stewart","year":"1982","unstructured":"Stewart, J. F. et al. Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer. Eur. J. Cancer Clin. Oncol. 18, 1307\u20131314 (1982).","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"9869_CR38","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-019-1019-4","volume":"567","author":"MMS Obradovi\u0107","year":"2019","unstructured":"Obradovi\u0107, M. M. S. et al. Glucocorticoids promote breast cancer metastasis. Nature 567, 540\u2013544 (2019).","journal-title":"Nature"},{"key":"9869_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2358","volume":"11","author":"F Behbod","year":"2009","unstructured":"Behbod, F. et al. An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ. Breast Cancer Res. 11, R66 (2009).","journal-title":"Breast Cancer Res."},{"key":"9869_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003293","volume":"4","author":"C Lee","year":"2012","unstructured":"Lee, C. et al. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci. Transl. Med. 4, 124ra127 (2012).","journal-title":"Sci. Transl. Med."},{"key":"9869_CR41","first-page":"2366","volume":"6","author":"J Zhang","year":"2013","unstructured":"Zhang, J. et al. Administration of dexamethasone protects mice against ischemia\/reperfusion induced renal injury by suppressing PI3K\/AKT signaling. Int. J. Clin. Exp. Pathol. 6, 2366\u20132375 (2013).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"9869_CR42","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1158\/0008-5472.CAN-24-2022","volume":"85","author":"C Lutz","year":"2025","unstructured":"Lutz, C. et al. Large-scale characterization of orthotopic cell line-derived xenografts identifies TGF-\u03b2 signaling as a key regulator of breast cancer morphology and aggressiveness. Cancer Res. 85, 2608\u20132625 (2025).","journal-title":"Cancer Res."},{"key":"9869_CR43","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.clnu.2017.06.017","volume":"36","author":"J Arends","year":"2017","unstructured":"Arends, J. et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin. Nutr. 36, 1187\u20131196 (2017).","journal-title":"Clin. Nutr."},{"key":"9869_CR44","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3945\/jn.112.168021","volume":"143","author":"PT Reidy","year":"2013","unstructured":"Reidy, P. T. et al. Protein blend ingestion following resistance exercise promotes human muscle protein synthesis. J. Nutr. 143, 410\u2013416 (2013).","journal-title":"J. Nutr."},{"key":"9869_CR45","doi-asserted-by":"publisher","first-page":"e201800115","DOI":"10.26508\/lsa.201800115","volume":"2","author":"AA Singh","year":"2019","unstructured":"Singh, A. A. et al. Optimized ChIP-seq method facilitates transcription factor profiling in human tumors. Life Sci. Alliance 2, e201800115 (2019).","journal-title":"Life Sci. Alliance"},{"key":"9869_CR46","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"9869_CR47","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ram\u00edrez","year":"2016","unstructured":"Ram\u00edrez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160\u2013W165 (2016).","journal-title":"Nucleic Acids Res."},{"key":"9869_CR48","doi-asserted-by":"publisher","first-page":"7938","DOI":"10.1093\/nar\/gkac613","volume":"50","author":"S Gregoricchio","year":"2022","unstructured":"Gregoricchio, S. et al. HDAC1 and PRC2 mediate combinatorial control in SPI1\/PU.1-dependent gene repression in murine erythroleukaemia. Nucleic Acids Res. 50, 7938\u20137958 (2022).","journal-title":"Nucleic Acids Res."},{"key":"9869_CR49","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature10730","volume":"481","author":"CS Ross-Innes","year":"2012","unstructured":"Ross-Innes, C. S. et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481, 389\u2013393 (2012).","journal-title":"Nature"},{"key":"9869_CR50","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L.-G. & He, Q.-Y. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382\u20132383 (2015).","journal-title":"Bioinformatics"},{"key":"9869_CR51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nmeth.4556","volume":"15","author":"RM Layer","year":"2018","unstructured":"Layer, R. M. et al. GIGGLE: a search engine for large-scale integrated genome analysis. Nat. Methods 15, 123\u2013126 (2018).","journal-title":"Nat. Methods"},{"key":"9869_CR52","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"9869_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"9869_CR54","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915 (2019).","journal-title":"Nat. Biotechnol."},{"key":"9869_CR55","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"9869_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"9869_CR57","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16, 284\u2013287 (2012).","journal-title":"Omics"},{"key":"9869_CR58","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-1-4939-3049-4_17","volume":"1355","author":"RR Jersie-Christensen","year":"2016","unstructured":"Jersie-Christensen, R. R., Sultan, A. & Olsen, J. V. Simple and reproducible sample preparation for single-shot phosphoproteomics with high sensitivity. Methods Mol. Biol. 1355, 251\u2013260 (2016).","journal-title":"Methods Mol. Biol."},{"key":"9869_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41\u201344 (2020).","journal-title":"Nat. Methods"},{"key":"9869_CR60","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731\u2013740 (2016).","journal-title":"Nat. Methods"},{"key":"9869_CR61","doi-asserted-by":"publisher","first-page":"W415","DOI":"10.1093\/nar\/gkae456","volume":"52","author":"JM Elizarraras","year":"2024","unstructured":"Elizarraras, J. M. et al. WebGestalt 2024: faster gene set analysis and new support for metabolomics and multi-omics. Nucleic Acids Res. 52, W415\u2013W421 (2024).","journal-title":"Nucleic Acids Res."},{"key":"9869_CR62","doi-asserted-by":"publisher","unstructured":"Gregoricchio, S. sebastian-gregoricchio\/SPACCa: v0.1.0 (0.1.0). Zenodo https:\/\/doi.org\/10.5281\/zenodo.15309654 (2025).","DOI":"10.5281\/zenodo.15309654"},{"key":"9869_CR63","doi-asserted-by":"publisher","first-page":"D1539","DOI":"10.1093\/nar\/gkac1040","volume":"51","author":"EW Deutsch","year":"2023","unstructured":"Deutsch, E. W. et al. The ProteomeXchange consortium at 10 years: 2023 update. Nucleic Acids Res. 51, D1539\u2013D1548 (2023).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09869-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09869-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09869-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:04:29Z","timestamp":1769213069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09869-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":63,"journal-issue":{"issue":"8098","published-print":{"date-parts":[[2026,1,22]]}},"alternative-id":["9869"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09869-0","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"29 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.N. and I.C. hold intellectual property rights on clinical uses of FMDs. C.V. and F.d.B. hold intellectual property rights on clinical uses of FMDs. F.L. reports honoraria as a speaker from Novartis, Pfizer and Accademia Nazionale di Medicina. C.V. and F.d.B. report roles in advisory boards, consultancy activity or having received honoraria as speakers from Pfizer, Novartis, Eli Lilly, Astra Zeneca, Daiichi Sankyo, Menarini Stemline, Gilead, MSD and Istituto Gentili. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}